UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 187 filers reported holding UNIQURE NV in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,875 | +2.3% | 12,500 | +371.7% | 0.00% | -33.3% |
| Q2 2021 | $82,000 | +115.8% | 2,650 | +152.4% | 0.00% | +50.0% |
| Q4 2020 | $38,000 | +660.0% | 1,050 | +1515.4% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 65 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -78.9% | 65 | -90.0% | 0.00% | -100.0% |
| Q4 2018 | $19,000 | -88.3% | 647 | -85.6% | 0.00% | -83.3% |
| Q3 2018 | $163,000 | +14.0% | 4,484 | 0.0% | 0.01% | +9.1% |
| Q2 2018 | $143,000 | +34.9% | 4,484 | -0.5% | 0.01% | +37.5% |
| Q1 2018 | $106,000 | +324.0% | 4,505 | +253.3% | 0.01% | +300.0% |
| Q4 2017 | $25,000 | – | 1,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |